Use of Bortezomib in recurrent and refractory multiple myeloma and impaired renal function

被引：0
|
作者：
Falcone, A. [1 ]
Sanpaolo, G. [1 ]
Bodenizza, C. [1 ]
Carella, A. M. [1 ]
Dell'Olio, M. [1 ]
Mantuano, S. [1 ]
Melillo, L. [1 ]
Merla, E. [1 ]
Scalzulli, F. [1 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [1] Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function
    Nozza, Andrea
    Siracusano, Licia
    Armando, Santoro
    CLINICAL THERAPEUTICS, 2006, 28 (06) : 953 - 959
  • [2] Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function
    Jagannath, S
    Barlogie, B
    Berenson, JR
    Singhal, S
    Alexanian, R
    Srkalovic, G
    Orlowski, RZ
    Richardson, PG
    Anderson, J
    Nix, D
    Esseltine, DL
    Anderson, KC
    CANCER, 2005, 103 (06) : 1195 - 1200
  • [3] Bortezomib in Relapsed/Refractory Multiple Myeloma
    Shen, Z.
    Wang, L.
    Yan, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62
  • [4] SALVAGE AND HEMATOPOIETIC RECOVERY WITH BORTEZOMIB AND MELPHALAN IN CYTOPENIC RECURRENT AND REFRACTORY MULTIPLE MYELOMA
    Mazumder, A.
    Vesole, D.
    Jagannath, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 72 - 72
  • [5] Teclistamab in patients with multiple myeloma and impaired renal function
    Joiner, Laura
    Bal, Susan
    Godby, Kelly N.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : E322 - E324
  • [6] Bortezomib in renally impaired multiple myeloma patients
    Miguel, J. F. San
    Richardson, P. G.
    Sonneveld, P.
    Schuster, M. W.
    Irwin, D.
    Stadtmauer, E. A.
    Facon, T.
    Harousseau, J. L.
    Ben-Yehuda, D.
    Lonial, S.
    Goldschmidt, H.
    Reece, D.
    Blade, J.
    Boccadoro, M.
    Neuwirth, R.
    Boral, A. L.
    Esseltine, D. L.
    Anderson, K. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 214 - 215
  • [7] The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
    Weber, D. M.
    Spencer, A.
    Wang, M.
    Chen, C.
    Attal, M.
    Niesvizky, R.
    Prince, M.
    Yu, Z.
    Knight, R.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function
    Dimopoulos, Meletios
    Alegre, Adrian
    Stadtmauer, Edward A.
    Goldschmidt, Hartmut
    Zonder, Jeffrey A.
    de Castro, Carlos M.
    Masliak, Zvenyslava
    Reece, Donna
    Olesnyckyj, Marta
    Yu, Zhinuan
    Weber, Donna M.
    CANCER, 2010, 116 (16) : 3807 - 3814
  • [9] Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma
    Van Keer, Jan
    Delforge, Michel
    Dierickx, Daan
    Peerlinck, Kathelijne
    Lerut, Evelyne
    Sprangers, Ben
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [10] Rapid Improvement in Renal Function in Patients with Multiple Myeloma and Renal Failure Treated with Bortezomib
    Qayum, Abdul
    Aleem, Aamer
    Al Diab, Abdel Rehman
    Niaz, Faraz
    Al Momen, Abdel Karim
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2010, 21 (01) : 63 - 68
12345